At the virtual interim meeting Nov. 13–17, the ACR delegation led a successful bid to update American Medical Association policies on home infusion and copay accumulators and supported efforts against the Most Favored Nation drug pricing model.
AMA House of Delegates Meeting Postponed Due to COVID-19, Advocacy Efforts Continue
Due to the COVID-19 pandemic, the AMA House of Delegates meeting planned for June has been canceled, but the ACR’s delegation remains ready to advocate for both ongoing and new rheumatology issues, including patient protections in step therapy, prior authorization and expansion of telehealth.
Advocacy Up Close: Dr. Gary Bryant Discusses the Role & Benefits of RheumPAC
RheumPAC, the ACR’s political action committee (PAC), is tasked with fundraising, vetting legislators, participating in Capitol Hill visits and developing important relationships for the College. During my interview with Gary Bryant, MD, the ACR’s inaugural RheumPAC chair, he shared his thoughts on the role of rheumatology advocacy in advancing clinical practice, research and education. ACR@Work: Have…
2018 ACR Awards of Distinction & ACR Masters
CHICAGO—At the 2018 ACR/ARHP Annual Meeting in October, the ACR and the ARHP honored distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the ACR winners about their individual contributions to advancing rheumatology. You’ll also find the 2018 Masters list. In the next issue,…